HAE logo

Haemonetics (HAE) EBIT

Annual EBIT

$164.88 M
+$8.85 M+5.67%

31 March 2024

HAE EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

$51.70 M
+$11.94 M+30.04%

28 September 2024

HAE Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

$167.37 M
+$16.39 M+10.86%

28 September 2024

HAE TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.7%+46.4%-0.1%
3 y3 years+83.7%+45.0%+314.5%
5 y5 years+97.4%+3.9%+88.9%

HAE EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+104.2%-3.7%+169.3%-6.5%+314.5%
5 y5 yearsat high+104.2%-12.1%+344.1%-6.5%+314.5%
alltimeall timeat high+475.2%-12.1%+184.5%-6.5%+402.0%

Haemonetics EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
$51.70 M(+30.0%)
$167.37 M(+10.9%)
June 2024
-
$39.76 M(+32.8%)
$150.98 M(-8.4%)
Mar 2024
$164.88 M(+5.7%)
-
-
Mar 2024
-
$29.94 M(-34.9%)
$164.88 M(-3.1%)
Dec 2023
-
$45.98 M(+30.2%)
$170.19 M(+1.6%)
Sept 2023
-
$35.30 M(-34.2%)
$167.50 M(-6.4%)
June 2023
-
$53.66 M(+52.2%)
$178.93 M(+14.7%)
Mar 2023
$156.03 M(+93.2%)
$35.26 M(-18.5%)
$156.03 M(+11.5%)
Dec 2022
-
$43.28 M(-7.4%)
$139.98 M(+5.8%)
Sept 2022
-
$46.73 M(+51.9%)
$132.35 M(+20.2%)
June 2022
-
$30.77 M(+60.3%)
$110.13 M(+36.4%)
Mar 2022
$80.75 M(-10.0%)
$19.20 M(-46.1%)
$80.75 M(+100.0%)
Dec 2021
-
$35.65 M(+45.5%)
$40.38 M(-10.6%)
Sept 2021
-
$24.51 M(+1663.3%)
$45.15 M(-43.2%)
June 2021
-
$1.39 M(-106.6%)
$79.42 M(-11.5%)
Mar 2021
$89.75 M(-13.2%)
-$21.18 M(-152.4%)
$89.75 M(-34.5%)
Dec 2020
-
$40.42 M(-31.2%)
$136.93 M(-0.4%)
Sept 2020
-
$58.78 M(+401.8%)
$137.41 M(+7.0%)
June 2020
-
$11.71 M(-55.0%)
$128.37 M(+24.2%)
Mar 2020
$103.35 M(+23.7%)
$26.01 M(-36.4%)
$103.35 M(+2.1%)
Dec 2019
-
$40.91 M(-17.8%)
$101.20 M(+14.2%)
Sept 2019
-
$49.74 M(-473.9%)
$88.61 M(+36.4%)
June 2019
-
-$13.30 M(-155.8%)
$64.95 M(-22.3%)
Mar 2019
$83.55 M(+30.2%)
$23.86 M(-15.8%)
$83.55 M(+13.0%)
Dec 2018
-
$28.32 M(+8.6%)
$73.96 M(+58.5%)
Sept 2018
-
$26.08 M(+392.7%)
$46.66 M(+4.1%)
June 2018
-
$5.29 M(-62.9%)
$44.84 M(-30.1%)
Mar 2018
$64.16 M(-431.0%)
$14.28 M(+1309.2%)
$64.16 M(-941.5%)
Dec 2017
-
$1.01 M(-95.8%)
-$7.62 M(-160.6%)
Sept 2017
-
$24.26 M(-1.4%)
$12.57 M(-4.1%)
June 2017
-
$24.61 M(-142.8%)
$13.11 M(-167.6%)
Mar 2017
-$19.38 M(-55.9%)
-$57.51 M(-371.1%)
-$19.38 M(-159.5%)
Dec 2016
-
$21.21 M(-14.4%)
$32.58 M(-165.4%)
Sept 2016
-
$24.79 M(-414.6%)
-$49.81 M(-10.1%)
June 2016
-
-$7.88 M(+42.0%)
-$55.43 M(+26.1%)
Mar 2016
-$43.94 M(-202.0%)
-$5.55 M(-90.9%)
-$43.94 M(+80.6%)
Dec 2015
-
-$61.18 M(-419.0%)
-$24.33 M(-144.2%)
Sept 2015
-
$19.18 M(+431.9%)
$55.11 M(+14.0%)
June 2015
-
$3.61 M(-74.4%)
$48.33 M(+12.2%)
Mar 2015
$43.06 M(-10.6%)
$14.06 M(-23.0%)
$43.06 M(+1.3%)
Dec 2014
-
$18.26 M(+47.2%)
$42.51 M(+0.9%)
Sept 2014
-
$12.41 M(-844.7%)
$42.11 M(-20.7%)
June 2014
-
-$1.67 M(-112.3%)
$53.13 M(+10.3%)
Mar 2014
$48.19 M(-20.6%)
$13.51 M(-24.4%)
$48.19 M(-14.9%)
Dec 2013
-
$17.86 M(-23.8%)
$56.64 M(+3.9%)
Sept 2013
-
$23.43 M(-454.6%)
$54.52 M(+33.0%)
June 2013
-
-$6.61 M(-130.1%)
$40.99 M(-32.4%)
Mar 2013
$60.68 M(-30.4%)
$21.95 M(+39.4%)
$60.68 M(+1.7%)
Dec 2012
-
$15.75 M(+59.0%)
$59.69 M(-13.8%)
Sept 2012
-
$9.90 M(-24.3%)
$69.26 M(-11.1%)
June 2012
-
$13.08 M(-37.6%)
$77.93 M(-12.2%)
Mar 2012
$87.18 M(-19.8%)
$20.96 M(-17.2%)
$88.76 M(-6.4%)
Dec 2011
-
$25.32 M(+36.4%)
$94.80 M(-3.3%)
Sept 2011
-
$18.57 M(-22.3%)
$98.03 M(-9.5%)
June 2011
-
$23.91 M(-11.5%)
$108.37 M(-0.6%)
Mar 2011
$108.65 M(+32.5%)
$27.00 M(-5.5%)
$108.99 M(+26.9%)
Dec 2010
-
$28.56 M(-1.2%)
$85.90 M(+3.5%)
Sept 2010
-
$28.91 M(+17.8%)
$82.97 M(+3.2%)
June 2010
-
$24.53 M(+527.5%)
$80.39 M(-2.0%)
Mar 2010
$82.01 M(-3.6%)
$3.91 M(-84.7%)
$82.01 M(-15.0%)
Dec 2009
-
$25.63 M(-2.7%)
$96.47 M(+2.2%)
Sept 2009
-
$26.32 M(+0.7%)
$94.36 M(+3.0%)
June 2009
-
$26.15 M(+42.3%)
$91.64 M(+8.0%)
Mar 2009
$85.07 M(+21.0%)
$18.38 M(-21.8%)
$84.83 M(-2.2%)
Dec 2008
-
$23.51 M(-0.4%)
$86.75 M(+4.7%)
Sept 2008
-
$23.61 M(+22.1%)
$82.84 M(+12.2%)
June 2008
-
$19.33 M(-4.7%)
$73.84 M(+5.1%)
Mar 2008
$70.29 M
$20.30 M(+3.6%)
$70.29 M(-6.9%)
Dec 2007
-
$19.60 M(+34.1%)
$75.46 M(+3.6%)
DateAnnualQuarterlyTTM
Sept 2007
-
$14.62 M(-7.4%)
$72.87 M(+0.4%)
June 2007
-
$15.78 M(-38.0%)
$72.55 M(+0.8%)
Mar 2007
$71.82 M(-27.5%)
$25.47 M(+49.8%)
$71.97 M(+2.3%)
Dec 2006
-
$17.00 M(+18.9%)
$70.34 M(-25.7%)
Sept 2006
-
$14.30 M(-5.9%)
$94.64 M(-1.1%)
June 2006
-
$15.20 M(-36.3%)
$95.72 M(-3.3%)
Mar 2006
$99.02 M(+65.2%)
$23.84 M(-42.3%)
$99.02 M(+8.9%)
Dec 2005
-
$41.31 M(+168.6%)
$90.95 M(+40.0%)
Sept 2005
-
$15.38 M(-16.8%)
$64.94 M(+2.3%)
June 2005
-
$18.50 M(+17.3%)
$63.48 M(+5.9%)
Mar 2005
$59.94 M(+26.7%)
$15.77 M(+3.1%)
$59.94 M(-0.6%)
Dec 2004
-
$15.30 M(+10.0%)
$60.28 M(+2.0%)
Sept 2004
-
$13.91 M(-7.0%)
$59.07 M(+8.8%)
June 2004
-
$14.96 M(-7.1%)
$54.30 M(+14.3%)
Mar 2004
$47.29 M(+26.2%)
$16.11 M(+14.3%)
$47.52 M(+26.5%)
Dec 2003
-
$14.10 M(+54.3%)
$37.55 M(+6.4%)
Sept 2003
-
$9.13 M(+11.6%)
$35.28 M(-1.9%)
June 2003
-
$8.19 M(+33.3%)
$35.97 M(-4.0%)
Mar 2003
$37.48 M(-19.3%)
$6.14 M(-48.1%)
$37.48 M(-28.6%)
Dec 2002
-
$11.82 M(+20.3%)
$52.50 M(+20.7%)
Sept 2002
-
$9.83 M(+1.4%)
$43.48 M(-6.7%)
June 2002
-
$9.69 M(-54.2%)
$46.61 M(-26.8%)
Mar 2002
$46.45 M(-17.8%)
$21.16 M(+654.0%)
$63.69 M(-10.8%)
Dec 2001
-
$2.81 M(-78.3%)
$71.41 M(-10.3%)
Sept 2001
-
$12.95 M(-51.6%)
$79.57 M(+6.2%)
June 2001
-
$26.77 M(-7.3%)
$74.91 M(+32.8%)
Mar 2001
$56.52 M(+17.2%)
$28.88 M(+163.3%)
$56.42 M(+10.3%)
Dec 2000
-
$10.97 M(+32.3%)
$51.16 M(+4.2%)
Sept 2000
-
$8.29 M(-0.0%)
$49.09 M(+2.1%)
June 2000
-
$8.29 M(-64.9%)
$48.11 M(-0.4%)
Mar 2000
$48.22 M(-14.2%)
$23.62 M(+165.4%)
$48.32 M(-17.4%)
Dec 1999
-
$8.90 M(+21.9%)
$58.49 M(+2.8%)
Sept 1999
-
$7.30 M(-14.1%)
$56.89 M(-1.2%)
June 1999
-
$8.50 M(-74.8%)
$57.59 M(+2.1%)
Mar 1999
$56.19 M(+81.3%)
$33.79 M(+362.8%)
$56.39 M(+143.1%)
Dec 1998
-
$7.30 M(-8.8%)
$23.20 M(-11.5%)
Sept 1998
-
$8.00 M(+9.6%)
$26.20 M(-2.2%)
June 1998
-
$7.30 M(+1116.7%)
$26.80 M(-7.9%)
Mar 1998
$31.00 M(-41.0%)
$600.00 K(-94.2%)
$29.10 M(-33.1%)
Dec 1997
-
$10.30 M(+19.8%)
$43.50 M(-0.2%)
Sept 1997
-
$8.60 M(-10.4%)
$43.60 M(-9.0%)
June 1997
-
$9.60 M(-36.0%)
$47.90 M(-8.8%)
Mar 1997
$52.50 M(-3.3%)
$15.00 M(+44.2%)
$52.50 M(+3.6%)
Dec 1996
-
$10.40 M(-19.4%)
$50.70 M(-6.5%)
Sept 1996
-
$12.90 M(-9.2%)
$54.20 M(-1.5%)
June 1996
-
$14.20 M(+7.6%)
$55.00 M(+1.3%)
Mar 1996
$54.30 M(+3.6%)
$13.20 M(-5.0%)
$54.30 M(+0.4%)
Dec 1995
-
$13.90 M(+1.5%)
$54.10 M(+1.7%)
Sept 1995
-
$13.70 M(+1.5%)
$53.20 M(-0.2%)
June 1995
-
$13.50 M(+3.8%)
$53.30 M(+1.5%)
Mar 1995
$52.40 M(+1.2%)
$13.00 M(0.0%)
$52.50 M(-1.9%)
Dec 1994
-
$13.00 M(-5.8%)
$53.50 M(-1.3%)
Sept 1994
-
$13.80 M(+8.7%)
$54.20 M(+1.5%)
June 1994
-
$12.70 M(-9.3%)
$53.40 M(+3.1%)
Mar 1994
$51.80 M(+23.9%)
$14.00 M(+2.2%)
$51.80 M(+4.6%)
Dec 1993
-
$13.70 M(+5.4%)
$49.50 M(+5.3%)
Sept 1993
-
$13.00 M(+17.1%)
$47.00 M(+6.1%)
June 1993
-
$11.10 M(-5.1%)
$44.30 M(+5.5%)
Mar 1993
$41.80 M(+39.8%)
$11.70 M(+4.5%)
$42.00 M(+6.6%)
Dec 1992
-
$11.20 M(+8.7%)
$39.40 M(+9.7%)
Sept 1992
-
$10.30 M(+17.0%)
$35.90 M(+10.1%)
June 1992
-
$8.80 M(-3.3%)
$32.60 M(+9.4%)
Mar 1992
$29.90 M(-81.0%)
$9.10 M(+18.2%)
$29.80 M(-50.4%)
Dec 1991
-
$7.70 M(+10.0%)
$60.10 M(-34.5%)
Sept 1991
-
$7.00 M(+16.7%)
$91.70 M(-26.0%)
June 1991
-
$6.00 M(-84.8%)
$124.00 M(-21.2%)
Mar 1991
$157.30 M
$39.40 M(+0.3%)
$157.30 M(+33.4%)
Dec 1990
-
$39.30 M(0.0%)
$117.90 M(+50.0%)
Sept 1990
-
$39.30 M(0.0%)
$78.60 M(+100.0%)
June 1990
-
$39.30 M
$39.30 M

FAQ

  • What is Haemonetics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Haemonetics?
  • What is Haemonetics annual EBIT year-on-year change?
  • What is Haemonetics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Haemonetics?
  • What is Haemonetics quarterly EBIT year-on-year change?
  • What is Haemonetics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Haemonetics?
  • What is Haemonetics TTM EBIT year-on-year change?

What is Haemonetics annual earnings before interest & taxes?

The current annual EBIT of HAE is $164.88 M

What is the all time high annual EBIT for Haemonetics?

Haemonetics all-time high annual earnings before interest & taxes is $262.10 M

What is Haemonetics annual EBIT year-on-year change?

Over the past year, HAE annual earnings before interest & taxes has changed by +$8.85 M (+5.67%)

What is Haemonetics quarterly earnings before interest & taxes?

The current quarterly EBIT of HAE is $51.70 M

What is the all time high quarterly EBIT for Haemonetics?

Haemonetics all-time high quarterly earnings before interest & taxes is $58.78 M

What is Haemonetics quarterly EBIT year-on-year change?

Over the past year, HAE quarterly earnings before interest & taxes has changed by +$16.39 M (+46.44%)

What is Haemonetics TTM earnings before interest & taxes?

The current TTM EBIT of HAE is $167.37 M

What is the all time high TTM EBIT for Haemonetics?

Haemonetics all-time high TTM earnings before interest & taxes is $178.93 M

What is Haemonetics TTM EBIT year-on-year change?

Over the past year, HAE TTM earnings before interest & taxes has changed by -$122.00 K (-0.07%)